Skip to content

Remifentanil and Nitroprusside for Controlled Hypotension

The Comparison of the Cardiovascular Effects of Remifentanil and Nitroprusside for Controlled Hypotension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02001298
Enrollment
30
Registered
2013-12-04
Start date
2012-06-30
Completion date
Unknown
Last updated
2013-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension, Controlled

Keywords

remifentanil, nitroprusside, hypotension

Brief summary

The purpose of this study is the comparison of the cardiovascular effects of remifentanil and nitroprusside for controlled hypotension

Interventions

DRUGremifentanil

Sponsors

Jeju National University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients who underwent endoscopic sinus surgery

Exclusion criteria

* patient who took any drug to influence this study * patient with cardiovascular disease, renal disease or liver disease

Design outcomes

Primary

MeasureTime frameDescription
Cardiac indexCardiac index was continuously measured during controlled hypotension, an average of 90 minCardiac index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of cardiac index during controlled hypotension was compared with baseline value.

Secondary

MeasureTime frameDescription
Total peripheral resistance indexTotal peripheral resistance index was continuously measured during controlled hypotension, an average of 90 minTotal peripheral resistance index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of total peripheral resistance index during controlled hypotension was compared with baseline value.

Other

MeasureTime frameDescription
Stroke volume indexStroke volume index was continuously measured during controlled hypotension, an average of 90 minStroke volume index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of stroke volume index during controlled hypotension was compared with baseline value.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026